Spontaneous resolution of acquired factor X deficiency in amyloidosis. 1993

A le Quellec, and A Sotto, and A J Ciurana
Department of Internal Medicine A, Saint-Eloi Hospital, Montpellier, France.

We describe the case of a 51-year-old man with systemic amyloidosis in whom factor X activity was initially 6% of the normal. Amyloidosis was responsible for congestive heart failure and a nephrotic syndrome but there was no bleeding diathesis. A 12-month trial of melphalan and prednisone failed to improve cardiac and renal dysfunction; factor X levels remained low. Eighteen months after this treatment was stopped, factor X spontaneously normalized although renal insufficiency persisted. We suggest that the possibility of a spontaneous factor X recovery must be considered when evaluating efficacy of therapeutic agents in amyloidosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D005171 Factor X Deficiency Blood coagulation disorder usually inherited as an autosomal recessive trait, though it can be acquired. It is characterized by defective activity in both the intrinsic and extrinsic pathways, impaired thromboplastin time, and impaired prothrombin consumption. Deficiency, Factor 10,Deficiency, Factor Ten,Deficiency, Factor X,Deficiency, Stuart-Prower,Deficiency, Stuart-Prower Factor,Factor 10 Deficiency,Factor Ten Deficiency,Stuart-Prower Deficiency,Stuart-Prower Factor Deficiency,Deficiencies, Factor 10,Deficiencies, Factor Ten,Deficiencies, Factor X,Deficiency, Stuart Prower,Deficiency, Stuart Prower Factor,Factor 10 Deficiencies,Factor Ten Deficiencies,Factor X Deficiencies,Stuart Prower Deficiency,Stuart Prower Factor Deficiency,Ten Deficiencies, Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses

Related Publications

A le Quellec, and A Sotto, and A J Ciurana
February 1977, American journal of clinical pathology,
A le Quellec, and A Sotto, and A J Ciurana
January 1987, Cleveland Clinic journal of medicine,
A le Quellec, and A Sotto, and A J Ciurana
June 1984, Medicina clinica,
A le Quellec, and A Sotto, and A J Ciurana
April 2011, NDT plus,
A le Quellec, and A Sotto, and A J Ciurana
September 2005, Haemophilia : the official journal of the World Federation of Hemophilia,
A le Quellec, and A Sotto, and A J Ciurana
December 2004, American journal of hematology,
A le Quellec, and A Sotto, and A J Ciurana
April 1987, The New England journal of medicine,
A le Quellec, and A Sotto, and A J Ciurana
December 1972, Schweizerische medizinische Wochenschrift,
A le Quellec, and A Sotto, and A J Ciurana
December 1972, Schweizerische medizinische Wochenschrift,
A le Quellec, and A Sotto, and A J Ciurana
July 1962, Thrombosis et diathesis haemorrhagica,
Copied contents to your clipboard!